Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUTO: Pyrimethamine, Lenalidomide, Topiramate in HIV
NCT07384624Phase 2Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyrimethamine, lenalidomide, topiramate in human immunodeficiency virus infection (HIV), sponsored by Erasmus MC. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
pyrimethaminelenalidomidetopiramate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07384624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07384624.